Skip to main content
BHF logo

BHF · Brighthouse Financial, Inc.

Track BHF — free
$41.11 -0.96 (-2.28%)
Market Cap
$2.42B
Shares
57.51M
Volume · Nov 18 565.54K Avg daily vol (3M) 919.76K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$42.07 Open$42.39 Day$41.79–42.85 52W close$41.10–66.61 Avg vol 30d819K Short int6.7M · 11.7% of shares · 8.9d Short vol51% Last earningsNov 7, 2025 DataJan 2020–Nov 2026 Filing10-Q · Nov 5

Up next

call held Aug 8, 2025

Latest documents

2026
Nov 5
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Merger talks pursue extension beyond December 6, 2026

Brighthouse Financial and Aquarian Parent are discussing extending the merger deadline after required insurance regulatory approvals were not expected by December 6, 2026.

Revenue $853M ▼ 53.0% Net income $328M ▼ 31.5% Diluted EPS $5.21 ▼ 34.0%
Read from the MD&A section
2 source passages
Pursuant to the terms of the Merger Agreement, on September 6, 2026, the Merger Agreement was automatically extended to December 6, 2026 (the “Outside Date”). The regulatory review process is ongoing, and the necessary regulatory approvals are not expected to be received in time to complete the Merger by the Outside Date. Accordingly, the Company and Aquarian Parent currently are in discussions regarding amending the Merger Agreement to extend the Outside Date Open the document at this passage
Nov 5
Current report 8-K
Merger extension talks follow third-quarter earnings decline

Brighthouse Financial reported third-quarter net income available to shareholders of $302 million, or $5.21 per diluted share, and is discussing extending its Aquarian Capital merger after regulatory approvals were not expected by December 6, 2026.

Financial results Read from the first part of this long document
3 source passages
The company reported net income available to shareholders of $302 million in the third quarter of 2026, or $5.21 per diluted share, compared with net income available to shareholders of $453 million in the third quarter of 2025, or $7.89 per diluted share. Pursuant to the terms of the merger agreement, on September 6, 2026, the merger agreement was automatically extended to December 6, 2026 (the “Outside Date”). Accordingly, the company and Aquarian Capital currently are in discussions regarding amending the merger agreement to extend the Outside Date and remain committed to the merger, although there can be no assurance that the company and Aquarian Capital will ultimately agree on an extension or that the merger will be completed by any such new outside date (or at all). Open the document at this passage
Aug 6
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $1.62B ▲ 86.2% Net income $981M ▲ 1054.1% Diluted EPS $16.53 ▲ 1520.6%
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$5.69B
Trailing 12 months
Net income (TTM)
$678.00M
Trailing 12 months
Revenue growth YoY
-53.0%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
4.3
Trailing earnings · reciprocal yield 23.2%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$5.37B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.6%
Year over year · more shares
Price change (1Y)
-36.0%
Trailing year
Short interest
11.7%
Latest settlement · 8.9 days to cover
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Low
Market backdrop VIX 24.6 · elevated Equity put/call 0.72
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −27%
below
Price vs 50-day avg −11%
below
RSI (14) 35
neutral
MACD trend Positive
52-week position 4%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −10%
trailing
6-month return −33%
trailing
YTD return −35%
this year
Relative strength −29%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $47 › 200d $58 — 200d above 50d
Institutional flow Distributing
-5% holders QoQ · +55 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
11.73% of shares out · ▼ -1.7% MoM · 8.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
464 holders — mid 3-yr range
Squeeze score 67
elevated · 0–100
Fundamentals
Excellent
Revenue growth +43%
Y/Y
EPS growth +23%
Y/Y
Valuation P/E 4.3
below peers
Buyback $441.0M
remaining
Balance sheet $2.2B
net cash
Quant / Vol
risk profile
Low
Volatility 18%
annualized · 1-yr
Max drawdown −38%
past year
ATR 3.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−27% Bearish
Price vs 50-day avg
−11% Bearish
RSI (14)
35 Neutral
MACD trend
Positive Bullish
52-week position
4% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $47 › 200d $58 — 200d above 50d
Institutional flow Distributing
-5% holders QoQ · +55 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
11.73% of shares out · ▼ -1.7% MoM · 8.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
464 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $41 Now $42 · 4% Range high $67
vs 200-day avg -27% vs 50-day avg -11%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted earnings (Life) non-GAAP 91M the third quarter of 2026 —
Adjusted earnings (loss) non-GAAP $527M the three months ended September 30, 2026 —
Adjusted earnings (Run-off) non-GAAP 166M the third quarter of 2026 —
Adjusted earnings, less notable items per diluted share non-GAAP $3.68 the third quarter of 2026 —
Book value per common share non-GAAP $57.59 As of September 30, 2026 —
Book value per common share, excluding AOCI non-GAAP $161.36 As of September 30, 2026 —
Book value, excluding AOCI 9.3B As of September 30, 2026 —
Combined total adjusted capital $4.8B As of September 30, 2026 —
Corporate expenses 204M the third quarter of 2026 —
Holding company liquid assets 1B As of September 30, 2026 —
Institutional spread margin business account balance, end of period $9.08B September 30, 2026 —
Life Insurance in-force, before reinsurance (Universal Life with Secondary Guarantees) $64.98B September 30, 2026 —
Net favorable notable items non-GAAP 314M the third quarter of 2026 —
Percent allocated to balanced funds 40.17% Three months ended September 30, 2026 —
Percent allocated to bond funds/other funds 9.09% Three months ended September 30, 2026 —
Percent allocated to equity funds 33.31% Three months ended September 30, 2026 —
Percent allocated to target volatility funds 17.43% Three months ended September 30, 2026 —
Statutory combined total adjusted capital 4.8B As of September 30, 2026 —
Total adjusted expenses non-GAAP $1.41B Three months ended September 30, 2026 —
Total adjusted revenues non-GAAP $2.1B Three months ended September 30, 2026 —
Total life sales $107M nine months ended September 30, 2026 —
Total notable items -$314M three months ended September 30, 2026 —
Total Quarterly VA separate account gross returns -1.19% three months ended September 30, 2026 —
Universal Life with Secondary Guarantees account value, end of period $4.25B September 30, 2026 —
Adjusted earnings (Total) non-GAAP $497M Six Months Ended June 30, 2026 —
Fixed Annuities account value, end of period $16.95B Q2 2026 —
Income annuity insurance liabilities, end of period $4.82B Q2 2026 —
Institutional group annuities account value, end of period $660M Q2 2026 —
Term Life insurance in-force, before reinsurance $300.62B Q2 2026 —
Term Life insurance in-force, net of reinsurance $249.86B Q2 2026 —
Universal and variable universal life account value, end of period $2.65B Q2 2026 —
Universal and Variable Universal Life insurance in-force, before reinsurance $40.45B Q2 2026 —
Universal and Variable Universal Life insurance in-force, net of reinsurance $31.23B Q2 2026 —
Variable and Shield Level Annuities account value, end of period $132.98B Q2 2026 —
Variable and Shield Level Annuities net flows -$2.42B Q2 2026 —
Variable universal life account value, end of period $7.21B Q2 2026 —
Whole Life insurance in-force, before reinsurance $15.75B Q2 2026 —
Whole Life insurance in-force, net of reinsurance $2.71B Q2 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Insurance - Life — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BHF
Brighthouse Financial, Inc.
this stock
$2.42B -35.1% +43.2% 4.3 11.7%
CILJF
China Life Insurance Co Ltd
$72.07B -26.1% — — 0.0%
MFC
Manulife Financial Corp
$71.05B +18.6% — — 0.8%
MET
Metlife Inc
$62.71B +26.4% +8.6% 13.0 1.7%
AFL
Aflac Inc
$61.96B +13.6% -9.3% 18.4 1.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
464
% held
91.0%
Net QoQ
-204.8K sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
286
View
Short & Settlement
Short Interest Falling
Shares short
6.7M
Days to cover
8.9d
Change
-115.1K sh
View
Short Volume
Short vol %
51%
As of
Nov 18, 2026
Short Total
View
Fails to Deliver
FTD shares
17.1K
Value
$734.1K
As of
Oct 30, 2026
View
Off-Exchange
Off-exchange %
51.6%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Jonathan Jackson
Amount
$15.0K–$50.0K
Traded
Apr 14, 2023
View
Financials
Financials
Revenue (FY)
$6.8B
Net income (FY)
$433.0M
EPS diluted
$5.71
View
Buybacks
Authorized
$750.0M
Remaining
$441.0M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 5, 2026
This year
17

Brighthouse Financial and Aquarian Parent are discussing extending the merger deadline after required insurance regulatory approvals were not expected by December 6, 2026.

View
Proposed Sales
Value
$492.7K
Shares
8.4K
Filed
Jun 3, 2025
View
Earnings & Events
Webcasts
Last webcast
Feb 12, 2026
View
Investor Relations
Latest news
Brighthouse Financial Announces C…
Published
Jan 13, 2022
View

Performance

5D 20D 120D MTD YTD
BHF -7.2% -10.4% -32.7% -4.2% -35.1%
SPY -3.9% -5.6% -3.5% -3.4% +7.1%
vs SPY -3.3% -4.9% -29.3% -0.8% -42.2%

Capital returns

Buyback program · as of Sep 30, 2026
Authorized
$750.00M
Spent (derived)
$309.00M
Remaining
$441.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1685040 CUSIP 10922N103 13F (30d) 464 filings 411 filers Visit website Investor relations